Newly released clinical trial data on the GLP-1 agonist drug Wegovy found that weight loss was sustained for up to four years ...

Researchers are looking to see if GLP-1 receptor agonists, DPP4 inhibitors, and SGLT2 inhibitors have beneficial effects in ...

Unregulated use of fentanyl and overdose deaths have increased dramatically in recent years, and this trend was made more ...

Semaglutide remains effective for weight loss at 4 years in people with preexisting cardiovascular disease and ...

Losing 80 pounds with the help of medication has brought a lot of positives — but Allie Olivares wants others to know it ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window One in eight U.S. adults have taken semaglutide ...

Kostas Biliouris, an analyst from BMO Capital, maintained the Buy rating on Centessa Pharmaceuticals (CNTA – Research Report). The ...

Ongoing registrational PRESent-2 and PRESent-3 studies of SerpinPC for the treatment of hemophilia B; PRESent-2 interim ...

The growing popularity of GLP-1 drugs opens up massive opportunities for biopharma companies, life sciences firms and ...

As mentioned above, Ozempic is a prescription-only treatment approved to treat type 2 diabetes, and it is the brand name for ...

The two companies will develop neuroplastogens for psychiatric disorders as psychedelic market activity ramps up.

Q1 2024 Earnings Call Transcript May 13, 2024 Operator: Good morning ladies and gentlemen. Thank you for standing by. Welcome ...